ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr...
Transcript of ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr...
![Page 1: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/1.jpg)
ADVANCES IN THE NUTRITIONAL MANAGEMENT OF HYPERPHOSPHATEMIA
AMONG HEMODIALYSIS PATIENTS
Rana G. Rizk, PhD, MPH, LD
Maastricht University, The Netherlands
November, 2017
![Page 2: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/2.jpg)
Learning objectives•Review the guidelines and available treatment options for
hyperphosphatemia among hemodialysis patients
• Examine the traditional approach to dietary management of hyperphosphatemia
•Recognize the importance of differentiating between sources of dietary phosphate in hyperphosphatemia management
•Discuss the best approach to dietary management of hyperphosphatemia
![Page 3: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/3.jpg)
Phosphate homoeostasis in humans
Penido & Alon, PediatrNephrol (2012) 27:2039-48
1500 mg
1100 mg
200 mg
900 mg
200 mg
600 mg
![Page 4: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/4.jpg)
Phosphate homoeostasis in CKD
Hruska et al., Kidney Int. 2008; 74(2): 148-57
![Page 5: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/5.jpg)
Hyperphosphatemia in hemodialysis
Egypt: 69.1% Lebanon: 40.4%
Wahbeh et al., 2011; Afifi et al., 2011; Karavetian et al., 2014; Port et al., 2006; Al Aly et al., 2016
Most common single mineral deviation from KDOQI guidelines
![Page 6: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/6.jpg)
Why do we care ?!Hyperphosphatemia & mortality
“Silent killer of hemodialysis
patients”
Block et al., J Am Soc Nephrol. 2004;15: 2208–18
![Page 7: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/7.jpg)
What is the evidence?
Hyperphosphatemia & adverse outcomes
Hyper-phosphatemia
↑ hospital-izations ↓ physical
functioning
↓ QOL
↑ pill burden
↑ cost
Other
Blayney & Tentori, 2009; Bover et al., 2009; Danese et al., 2008; Floege et al., 2011; Heymann et al., 2012; Hruska et al., 2011; Johansen & Chertow, 2007; Lee et al., 2007; Moorthie & Moe, 2011; Naves-Diaz et al., 2011; Roman-Garcia et al., 2009; Tentori et al., 2008; Young et al., 2004; Young et al., 2005
![Page 8: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/8.jpg)
Hyperphosphatemia management
Optimal dialysisPTH
control
Phosphate binders
Dietary restriction
KDIGO, 2009; KDOQI, 2003
![Page 9: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/9.jpg)
Traditional dietary phosphate restriction20 years ago dietitians emphasized controlling hyperphosphatemia by
absolute dietary phosphate restriction
![Page 10: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/10.jpg)
What is the evidence? Dietary phosphate restriction & mortality
• Post hoc analysis of data from the Hemodialysis Study (n=1751)•More restrictive phosphate prescription → poorer indices of nutritional status
Lynch et al., Clin J Am SocNephrol. 2011; 6: 620-9
30% ↑ survival
![Page 11: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/11.jpg)
Traditional dietary phosphate restrictionDid we miss anything ?!
Estimated phosphate intake (mg/dl)
calculated from daily protein intake (g/d) in hemodialysis patients from the NIED study
(n=107)
Kalantar-Zadeh et al., CJASN. 2010; 5:519-30
![Page 12: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/12.jpg)
What is the evidence? Dietary phosphate, protein & mortality
↑protein intake → ↑survival↑↑survival with simultaneous
↓ serum phosphate
Shinaberger et al., Am J Clin Nutr 2008;88:1511–8
The risk of controlling serum phosphate by restricting protein
- may ↑mortality- may outweigh the benefit of
controlled phosphate
n=30,075
![Page 13: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/13.jpg)
Phosphorus-to-protein ratio
![Page 14: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/14.jpg)
Phosphorus-to-protein ratio•Advantages• Simultaneous representation of dietary phosphate & protein• Helps in selecting foods with desirable ratio & not solely based upon phosphate content• Emphasize foods with high amount of phosphate additives but having similar amount of
dietary protein•Does not depend on the food portion being served
•Disadvantages• Sometimes difficult to calculate• Variations & inaccuracies in estimations of phosphate content
•Does not give any information about phosphate bioavailabilityKDOQI, 2003
![Page 15: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/15.jpg)
What is it with phosphate sources ?!≈100%
40-80%
20-40%
Vervloet et al., Nat Rev Nephrol. 2017; 13:27-38
![Page 16: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/16.jpg)
What is it with phosphate bioavailability ?!The role of Phytate
Phosphate in meat is easily hydrolyzed & readily absorbed
Phosphate in plants is mostly in phytic
acid or phytate form (75%)
Humans do not express phytase(low phosphate bioavailability:
<50%)
↓ intestinal phosphate
absorption per gram of plant vs. animal-
based protein
Plant foods are less likely to ↑
phosphate burden
Kalantar-Zadeh et al., CJASN. 2010; 5:519-30
![Page 17: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/17.jpg)
What is it with phosphate bioavailability ?!The role of Phytate
The traditional approach of totally restricting intake of beans, peas, seeds & chocolate is of no major relevance ?
• Important considerations• Even with ↓ fractional rate of intestinal absorption,
↑ intake can still lead to excessive phosphate burden• Some seeds & beans ↑ potassium → hyperkalemia• Yeast-based phytase in whole grains:
↑ absorption of phosphate in leavened breads than cereals or flat breads• Unclear effect of probiotics on phosphate absorption
Kalantar-Zadeh et al., CJASN. 2010; 5:519-30
![Page 18: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/18.jpg)
What is it with protein digestibility ?!Ratio adjusted for digestion & absorption
Considers digestibility of protein & bioavailability of phosphate
KDOQI, 2009; Beto et al., Int J Nephrol Renovasc Dis. 2016;9:21-33
Protein digestibility
Animal proteins: 95%
Plant proteins: 85%
Mixed meals:85% to 95%
![Page 19: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/19.jpg)
Phosphate bioavailability studies in humans for various dietary protein sources are needed to provide comprehensive evidence-based identification
of preferred dietary sources KDOQI, 2009; Beto et al., Int J Nephrol Renovasc Dis. 2016;9:21-33
![Page 20: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/20.jpg)
Focus on avoiding phosphate additives • Consumption of phosphate additives: ≈ 1000 mg/day• 2 servings of additive-containing chicken products: 880 mg
•Difficult to precisely determine• Food industry is not required to report the quantity used• Only listing the additives used in the ingredient list
• Concerns of underestimation of dietary phosphate intake• Processed foods• ↑ inorganic phosphate load • ↓ nutritional value• Often paired with sodium & potassium additives
Biruete et al., J Ren Nut. 2017;31:62-70
![Page 21: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/21.jpg)
Hidden phosphate !!!
![Page 22: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/22.jpg)
International survey of renal care professionals
Fouque et al., J Ren Nut. 2014;24:110-5
![Page 23: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/23.jpg)
Focus on avoiding phosphate additives • Cluster RCT
• n=279; with serum phosphorus levels >5.5 mg/dL
• Counseling on avoiding phosphate additives vs. standard recommendations• 30 minutes of education • Reading food labels/ avoiding phosphorus-containing additives when purchasing food• Providing renal-friendly options when eating at fast-food restaurants
Sullivan et al., JAMA. 2009;301:629-35
![Page 24: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/24.jpg)
Executive summary of the 2017 KDIGO CKD-MBD Guideline update: What’s changed and why it matters
Limiting phosphate intakewith phosphate sources as additional qualifier
KDIGO, 2017
Not all Phosphate is created equal
![Page 25: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/25.jpg)
Cooking techniques to reduce phosphate content•Boiling of sliced food using pressure cooker & discarding water• Soaking in cold water (4°C) for 1 hour before thermal processing• Significant reduction of phosphate content while preserving protein content
Ando et al., J Ren Nut.2015;25:504-9
![Page 26: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/26.jpg)
Cooking techniques to reduce phosphate content
• Patients’ feedback• Straightforward processing instructions• Product satisfactory vis-à-vis texture & visual appeal, slightly "bland" taste• "Demineralization" rated positively; "Leaching" & "dialyzing" rated "somewhat negative“, "unappealing"
Jones, J Ren Nut.2001;11:90-6
![Page 27: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/27.jpg)
![Page 28: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/28.jpg)
P/protein ratio
Take-home message
Dietary phosphate restriction
Greater focus on:1) Avoiding added phosphate2) Better appreciating that natural
phosphate is not well absorbed3) Wet cooking techniques4) Diligent use of phosphate binders5) Patient education & counseling
800-1000
mg/day
Judicious dietary phosphate restriction while maintaining adequate dietary protein intake
Toussaint et al., Nephrology. 2017;22,
(Suppl. 2):36–41
P content
P bioavaila
bility
![Page 29: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg](https://reader034.fdocuments.in/reader034/viewer/2022042222/5ec8280669ee91782538aaf3/html5/thumbnails/29.jpg)
Thank you !